drugset / Trial / NCT03096093
Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer
Phase 1/2
Active not recruiting
34 enrolled
Cancer Vaccines Limited
Cancer Research UK · collabCancer Vaccines Charitable Trust · collabLiverpool University Hospitals NHS Foundation Trust · collabNational Institute for Health Research, United Kingdom · collabThe Clatterbridge Cancer Centre NHS Foundation Trust · collabUniversity of Liverpool · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study evaluates four different doses of ACIT-1 for safety and for the ability to raise effective anti-cancer immune responses in patients with pancreatic and other cancers. Approximately half of the patients will have pancreatic cancer and the other half will have other cancers.
Timeline
- Start
- 2017-04-25
- Primary completion
- 2026-12
- Completion
- 2027-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ACIT-1 | Cell therapy | 100000 cells | Other |
| Subject | ACIT-1 | Cell therapy | 1e+07 cells | Other |
| Subject | ACIT-1 | Cell therapy | 3e+07 cells | Other |
| Subject | ACIT-1 | Cell therapy | 1e+08 cells | Other |